Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes - PubMed (original) (raw)

Randomized Controlled Trial

. 2010 Sep;53(9):1846-55.

doi: 10.1007/s00125-010-1806-9. Epub 2010 Jun 6.

Affiliations

Randomized Controlled Trial

Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes

M-R Taskinen et al. Diabetologia. 2010 Sep.

Abstract

Aims/hypothesis: The apolipoprotein B (ApoB):apolipoprotein A (ApoA)-I ratio may be a better indicator of cardiovascular disease (CVD) risk in people with type 2 diabetes than traditional lipid risk markers (LDL-cholesterol, HDL-cholesterol and triacylglycerol), but whether the ApoB:ApoA-I ratio should be used to indicate lipid-lowering therapy is still debated.

Methods: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study randomised 9,795 patients with type 2 diabetes to fenofibrate (200 mg daily) or placebo and followed them up for a median of 5 years. We compared ApoB, ApoA-I, ApoAII and the ApoB:ApoA-I ratio with traditional lipid variables as predictors of CVD risk. We estimated the HR of the effect of 1 SD difference in baseline concentrations of lipids, apolipoproteins and respective ratios on the risk of CVD events and also used receiver operating characteristic curve analysis.

Results: In the placebo group, the variables best predicting CVD events were non-HDL-cholesterol:HDL-cholesterol, total cholesterol:HDL-cholesterol (HR 1.21, p < 0.001 for both), ApoB:ApoA-I (HR 1.20, p < 0.001), LDL-cholesterol:HDL-cholesterol (HR 1.17, p < 0.001), HDL-cholesterol (HR 0.84, p < 0.001) and ApoA-I (HR 0.85, p < 0.001). In the fenofibrate group, the first four predictors were very similar (but ApoB:ApoA-I was fourth), followed by non-HDL-cholesterol and ApoB. Lipid ratios and ApoB:ApoA-I performed better than any single lipid or apolipoprotein in predicting CVD risk.

Conclusions/interpretation: In patients with type 2 diabetes in the FIELD study, traditional lipid ratios were as strong as the ApoB:ApoA-I ratio in predicting CVD risk. The data provide little evidence for replacement of traditional lipids and their ratios with measures of ApoB, ApoA-I and their ratio.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Am Coll Cardiol. 2007 Feb 6;49(5):547-53 - PubMed
    1. Metabolism. 1992 May;41(5):498-503 - PubMed
    1. Circulation. 2007 Oct 30;116(18):2029-35 - PubMed
    1. Nat Clin Pract Endocrinol Metab. 2009 Mar;5(3):150-9 - PubMed
    1. Circulation. 2005 Nov 29;112(22):3368-70 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources